Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics Corp (UTHR) · filed Nov 12, 2025

Accession no.
0001673232-25-000011
Filed
Nov 12, 2025
Trade date
Nov 10, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.2M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 10, 2025Common StockMOption exerciseDisposed−14,625$135.42−$1,980,517.514,625Indirect
Nov 10, 2025Common StockSSaleDisposed−14,625$452.09−$6,611,816.250Indirect
Nov 10, 2025Common StockMOption exerciseAcquired+7,875$146.03+$1,149,986.257,875Indirect
Nov 10, 2025Common StockSSaleDisposed−7,875$452.04−$3,559,8150Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 10, 2025Common StockMOption exerciseDisposed−14,625$0.00$026,625Indirect
Nov 10, 2025Common StockMOption exerciseDisposed−7,875$0.00$02,625Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)